Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD)
Phase 2
Active, not recruiting
- Conditions
- Mild Cognitive Impairment Due to Alzheimer's DiseaseAlzheimer's Disease, Early Onset
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-12-26
- Last Posted Date
- 2025-02-26
- Lead Sponsor
- PRInnovation GmbH
- Target Recruit Count
- 270
- Registration Number
- NCT06182085
- Locations
- 🇨🇿
Neuro Health Centrum ltd., Brno, Czechia
🇨🇿NeuropsychiatrieHK, s.r.o., Hradec Králové, Czechia
🇨🇿A-Shine, s.r.o., Plzen, Czechia
© Copyright 2025. All Rights Reserved by MedPath